2110 POSTER Active specific immunotherapy with NGcGM3/ VSSP/ Montanide ISA-51 (CIMAVaxG) vaccine in the treatment of patients with metastatic breast cancer: Results of a randomized phase II clinical trial

2007 ◽  
Vol 5 (4) ◽  
pp. 217
Author(s):  
A. Macias ◽  
A. Torres ◽  
A. Montenegro ◽  
P. Marinello ◽  
R. Rodriguez ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Clinical Trial ◽  
Metastatic Breast Cancer ◽  
Phase Ii ◽  
Specific Immunotherapy ◽  
Metastatic Breast ◽  
Phase Ii Clinical Trial ◽  
Active Specific Immunotherapy ◽  
Randomized Phase Ii

Final Results of a Phase II Clinical Trial of Weekly Docetaxel in Combination with Capecitabine in Anthracycline-Pretreated Metastatic Breast Cancer

2004 ◽  
Vol 5 (4) ◽  
pp. 287-292 ◽  
Author(s):  
John R. Mackey ◽  
Katia S. Tonkin ◽  
Sheryl L. Koski ◽  
Andrew G. Scarfe ◽  
Michael G.B. Smylie ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Clinical Trial ◽  
Metastatic Breast Cancer ◽  
Phase Ii ◽  
Metastatic Breast ◽  
Phase Ii Clinical Trial ◽  
Weekly Docetaxel

Preliminary Results or a Phase II Clinical Trial Utilising Tru-Scint® AD™ in Primary and Metastatic Breast Cancer

1994 ◽  
Vol 19 (10) ◽  
pp. 932
Author(s):  
A. J.B. McEwan ◽  
G. D. MacLean ◽  
L. Golberg ◽  
K. Golberg ◽  
G. R. Boniface ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Clinical Trial ◽  
Metastatic Breast Cancer ◽  
Phase Ii ◽  
Metastatic Breast ◽  
Phase Ii Clinical Trial ◽  
Preliminary Results

Phase II Clinical Trial of Titanocene Dichloride in Patients with Metastatic Breast Cancer

2000 ◽  
Vol 23 (1) ◽  
pp. 60-62 ◽  
Author(s):  
N. Kröger ◽  
U.R. Kleeberg ◽  
K. Mross ◽  
L Edler ◽  
D.K. Hossfeld
Keyword(s):  
Breast Cancer ◽  
Clinical Trial ◽  
Metastatic Breast Cancer ◽  
Phase Ii ◽  
Metastatic Breast ◽  
Phase Ii Clinical Trial ◽  
Titanocene Dichloride
Sign in / Sign up

Export Citation Format

Share Document